Designed to help clinicians overcome catheter identification confusion

WAYNE, Pa., June 07, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced the launch of an Arrow Pressure Injectable Midline Catheter in Europe, the Middle East and Africa region. The addition of the pressure injectable catheter further enhances the Midline portfolio to meet the expanded needs of clinicians and is designed to improve patient safety.

The new, 20cm Arrow Pressure Injectable Midline with brightly colored yellow hubs and labeling, will help clinicians overcome catheter identification confusion, which can lead to infusion mistakes that can harm patients. Additional features include:

Available in 1-lumen and 2-lumen configurations

TAPERFREE design, which assures consistent French size from distal tip to catheter hub to reduce the risk of venous stasis. This design is aligned with INS standards to select a catheter with a 45% or less catheter to vein ratio from the distal tip to hub

Tray configuration designed to facilitate procedural efficiency

Arrow Ergonomic trimmer that allows multiple, precise cuts with its window for easy visualisation of centimeter markings on the catheter

Additional sharps safety componentry to meet INS standards

“The new catheter design is a direct result of our partnership with clinicians and exemplifies how we work together to identify needs and develop solutions that help them improve patient care,” said Matthew James, President EMEA for Teleflex. “We are excited to bring the Arrow Pressure Injectable Midline catheter to the market here in the region and to expand our portfolio in ways that meet the many needs of vascular access.”

The new Arrow Pressure Injectable Midline allows for pressure injection up to 5 mL/second through either lumen to mitigate diagnostic and treatment delays of having to replace a secondary device.

About Teleflex Incorporated Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow, Deknatel, LMA®, Pilling, QuikClot, Rüsch, UroLift, and Weck – trusted brands united by a common sense of purpose.

Forward-Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo, Arrow, Deknatel, LMA, Pilling, QuikClot, Rüsch, UroLift, Weck and TAPERFREE are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.

© 2022 Teleflex Incorporated. All rights reserved. MCI-100825 Rev 1 05 22

Lawrence Keusch Vice President, Investor Relations and Strategy Development

John Hsu, CFA Vice President, Investor Relations

investors.teleflex.com 610-948-2836

The number of companies stepping up to cover travel costs for U.S. employees seeking abortion services is growing following a decision by the U.S. Supreme Court on Friday to overturn its landmark Roe v. Wade.

The FDA has been banned Juul from the U.S. markets on safety and marketing concerns.

Dr. Anthony Fauci, the nation's top infectious disease expert, says his COVID-19 recovery is an “example” for the nation on the protection offered by vaccines and boosters. Speaking during a White House briefing, Fauci, 81, said he began experiencing virus symptoms on June 14 and tested positive a day later. “I’m still feeling really quite fine,” Fauci said Thursday, as the administration emphasized the protection offered by vaccines to people of all ages, after the U.S. became the first country in the world to extend vaccine eligibility to children as young as six months.

Is Pfizer stock a buy after the FDA signed off on its Covid vaccine for babies and toddlers? Is PFE stock a buy right now?

"It has been 16 years, but I can still hear myself begging my mother, my doctor, not to make me do this ― please don’t make me do this."

The FDA has banned all JUUL products from shelves across the country due to potentially harmful chemical leeching concerns

Biogen Inc. said in a statement that it stopped a post-marketing clinical trial testing its Alzheimer's disease therapy Aduhelm, citing a Medicare policy that will limit usage of the drug. The company updated the study's ClinicalTrials.gov

She also got real about how her "weight fluctuates" due to perimenopause (and that she's okay with that) in a recent Instagram post.

Kentucky recorded abortions at six facilities in 2020, according to a state report. Where were the procedures performed, and what types were the most common? Here’s the commonwealth’s data.

Polio can cause paralysis in rare cases and can be life-threatening.

How to protect yourself, your kids and your pets from tick bites.

Aura Biosciences Inc (NASDAQ: AURA) reported data from a retrospective analysis that assessed the visual acuity after plaque radiotherapy treatment compared with prospective data in early-stage choroidal melanoma patients treated with belzupacap sarotalocan by intravitreal administration in the Phase 1b/2 trial. The vision results of patients with early-stage choroidal melanoma treated with radiotherapy showed the long-term, progressive, and irreversible loss of visual acuity in patients with tu

‘All is well with Fauci’ the White House's chief medical adviser said during a COVID-19 Response Team briefing, He also took Paxlovid to treat his COVID case.

By Wendy Carruthers, Senior Vice President HR at Boston Scientific

Everyone has bad habits, but there's some behaviors we do that are actually more harmful than we think. Unhealthy habits can have long-term negative consequences and Dr. Charles Tabone N.M.D a Naturopathic Medical Doctor with Pause Studio tells us five things people do on a regular basis that should be stopped immediately. Read on to find out more—and to ensure your health and the health of others, don't miss Already Had COVID? These Symptoms May "Never Go Away". 1 Don't Throw Caution to the Win

Members of the Congressional Black Caucus (CBC) are urging President Biden to declare a national emergency in response to the Supreme Court’s decision striking down the Roe v. Wade ruling on abortion rights. In a letter to Biden, the CBC members said he should use “every tool” at his disposal to protect access to abortion…

He is in the intensive-care unit at a local hospital, according to local media reports.

The U.S. Supreme Court on Friday overturned its landmark decision Roe v. Wade that for nearly 50 years has secured women's federal right to obtain an abortion.

The North Carolina Department of Health and Human Services reported the first case of monkeypox in the state.

Maria Shriver is speaking out in the wake of the overturning of Roe v. Wade. The 1973 decision, which ruled that the U.S. Constitution protected a pregnant person's right to an abortion, was overturned on Friday.